Drug intelligence / Profile preview

Citro-Soda

Development stage: Unknown
Lead developer: ADOCK Ingram
Modality: Small Molecules
Administration: Oral

Overview

Citro-Soda is an over-the-counter (OTC) effervescent formulation developed and marketed by Adcock Ingram. It functions as both a gastric antacid and a urinary alkalinizing agent. The product is composed of a combination of sodium bicarbonate, tartaric acid, citric acid, and sodium citrate. It is primarily indicated for the symptomatic relief of heartburn and acid indigestion by neutralizing excess gastric acid. Additionally, it is used to alleviate the discomfort associated with urinary tract infections (UTIs) and to manage high uric acid levels (hyperuricemia) related to gout by increasing the pH of the urine. The effervescent granules are typically dissolved in water for oral administration.

Brand names: Citro-Soda

Beyond the preview

Go deeper on Citro-Soda.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Citro-Soda.

Explore the full profile